ClinicalTrials.gg
RecruitingNCT07754110Updated Aug 10, 2026

Effect of HABIT-ILE on Balance and Coordination Among Stroke Patients

An interventional study of Lower Extremity HABIT-ILE GROUP A and group B Conventional treatment ( Conventional Treatment in Stroke (CVA) or Transient Ischemic Attack, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Study summary

Strokes frequently affect motor function, balance, and coordination, reducing independence. HABIT-ILE combines upper and lower limb exercises to improve coordination and balance.

Objective To determine the effectiveness of HABIT-ILE on balance and coordination among stroke patients.

we used randomized controlled trails (two-arm parallel design) on 44 people who were allocated evenly into two groups using purposive sampling. The Berg Balance Scale, Finger-to-Nose Test, and 6-Minute Walk Test were administered during a six-month period at HHRD Center, Mansehra. Data was analyzed using SPSS 25 with repeated measures ANOVA and the Shapiro-Wilk test to ensure normality

Read the detailed description

Stroke often causes weakness, impaired coordination, and poor balance, leading to difficulties in performing daily activities independently. HABIT-ILE (Hand-Arm Bimanual Intensive Therapy Including Lower Extremity) is a task-oriented rehabilitation approach that focuses on intensive, repetitive practice of coordinated movements involving both upper limbs and lower extremities. It aims to improve motor control, balance, gait, and functional independence by encouraging the use of the affected side during meaningful activities.

The purpose of this topic is to evaluate the effectiveness of HABIT-ILE in improving balance and coordination among stroke patients. By enhancing bilateral limb function and postural control, this therapy may help patients regain mobility, reduce the risk of falls, and improve their overall quality of life. The findings may provide evidence for incorporating HABIT-ILE into stroke rehabilitation programs to achieve better functional outcomes.

02

Conditions studied

  • Stroke (CVA) or Transient Ischemic Attack
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 44 is below the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants falling in the following category would be recruited into the study:

    1. A hemiplegic patient due to unilateral stroke
    2. Patients having sub-acute and chronic stroke
    3. Stroke survivors between 40 and 60years old
    4. Both genders
    5. A hemiparetic patient with a chronic stroke (over 6 months of evolution)

Exclusion criteria

Exclusion Criteria:

  • Participants falling in the following category would be excluded from the study:

    1. Pregnancy
    2. Major cognitive impairment interfering with the study (severe aphasia, psychiatric conditions)
    3. Uncontrolled health issues (cardiac/renal failure)
    4. Patients with depression who will be unable to cooperate during treatment
    5. Patients who cannot perform the active movement of limb due to pre-stroke musculoskeletal problems
    6. Cardiopulmonary diseases which could hinder their ability to participate in rehabilitation
    7. Patients with any neuron disease and with lower-limb impairment caused by other neurological diseases
    8. Visual and auditory abnormalities
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Lower Extremity HABIT-ILE GROUP A

    Hand Arm Bimanual intensive therapy including lower extremity (HABIT-ILE) is among the few neuro-rehabilitation treatments that specifically target UE and LE

    Other: Lower Extremity HABIT-ILE GROUP A

  • Active comparator
    group B Conventional treatment

    Conventional physical therapy intervention The conventional physical therapy intervention included 5 minutes of range of motion, 10 minutes of stretching, 10 minutes of strengthening, and 5 minutes of muscle relaxation in each 30-minute session. Stretching tight muscles and strengthening weak muscles were the main focus of each session.

    Other: group B Conventional treatment ( Conventional Treatment

Interventions

  • OtherLower Extremity HABIT-ILE GROUP A

    Hand Arm Bimanual intensive therapy including lower extremity (HABIT-ILE) is among the few neuro-rehabilitation treatments that specifically target UE and LE (19) This method uses concepts from motor skill learning in intensive training; it calls for postural control and continuous stimulation of UE and LE through various activities that are done continuously, progressively more difficult, for two hours every day for three weeks in group therapy (20) It is suggested that participants engage in structured tasks that gradually increase in motor complexity based on their development. Similarly, it involves postural and/or locomotor movements as well as functional tasks that call for the simultaneous use of both hands. (21) A variety of exercises that test the patient's ability to utilize their lower extremities to carry out daily duties are usually included in the rehabilitation program

  • Othergroup B Conventional treatment ( Conventional Treatment

    Conventional physical therapy intervention The conventional physical therapy intervention included 5 minutes of range of motion, 10 minutes of stretching, 10 minutes of strengthening, and 5 minutes of muscle relaxation in each 30-minute session. Stretching tight muscles and strengthening weak muscles were the main focus of each session.

06

What researchers measure

Primary outcomes

  1. Finger to nose test

    The finger-to-nose test (FNT) is a basic and simple physical examination that has been conventionally used to examine cerebellar function. In the FNT, patients are asked to alternately touch their own nose and the evaluator's stationary or moving finger while lying supine, or while sitting or standing. The Finger-to-Nose-Test measures smooth, coordinated upper-extremity movement by having the examinee touch the tip of his or her nose with his or her index finger. On one variation of the test, the examiner holds out his or her finger, about an arm's length from the patient. The patient is instructed to touch the examiner's finger, then his or her own nose. After several successful trials, the patient is then asked to repeat the action more quickly. Moving the target finger can increase the difficulty of the task. This test is part of a comprehensive neurological examination. It is typically employed as part of coordination testing. The examiner looks for evidence of intention tremor or

    Time frame: 6 Weeks

  2. berg balance scale

    The Berg Balance Scale is a testing tool with high validity and reliability used to measure balance. Balance gives an individual the ability to achieve physical movement and further carry out the activities of daily living. A five-point scale, ranging from 0-4. "0" indicates the lowest level of function and "4" the highest level of function. Total Score = 0-56. Score of 41-56 = low fall risk, 21-40 = medium fall risk, 0-20 = high fall risk. The Berg Balance Scale has a high relative reliability with interrater reliability estimatedat0.97 (95% CI 0.96 to 0.98) and interrater reliability estimated at 0.98 (95%CI0.97to0.99). The absolute reliability of the Berg Balance Scale varies across the scale, with minimal detectable change with 95%confidencevaryingbetween 2.8/56 and 6.6/56

    Time frame: 6 weeks

  3. 6 min walk test

    An increase in the distance walked indicates improvement in basic mobility. Resnik et al (2011) suggested in Amputee rehabilitation, Post training a difference of at least 45m should be observed for the 6 minute walk test to be sure that a "real" change in the patient's condition. The six-minute walk test is a simple cardiopulmonary functional testing modality. Its straightforward nature allows for a non-specific, integrated assessment of the many systems involved during physical activity. Specifically, its results can assist in ascertaining the degree of functional impairment and potentially lead to modifications in therapy for some cardiovascular and pulmonary conditions. This activity reviews the six-minute walking test, its physiological basis, uses in practice, and outlines the role of the healthcare team in its performance.

    Time frame: 6 weeks

07

Study locations

1 of 1 sites recruiting
  • in helping hands institute of comprehensive therapy MANSEHRA
    Mansehra, Kpk 22020, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07754110
Responsible party
Sponsor
First posted
Aug 10, 2026
Start date
Jul 30, 2026
Primary completion
Jan 30, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Aug 10, 2026

Study contacts

mahat Zafar, MS.Nmpt
Contact
mahat.zafar@riphah.edu.pk
03326624087 ext. 03326624087
Mahat zafar, MS NMPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion